期刊文献+

甲磺酸沙喹那韦三甲基壳聚糖微球的制备

Preparation of Saquinavir Mesylate Loaded N-trimethyl Chitosan Microspheres
下载PDF
导出
摘要 为了提高甲磺酸沙喹那韦的生物利用度,制备了甲磺酸沙喹那韦三甲基壳聚糖微球并考察其体外溶出度。用喷雾干燥法制备甲磺酸沙喹那韦三甲基壳聚糖微球,用红外光谱进行鉴定,采用PBS7.4缓冲液和0.1 mol/L盐酸溶液考察微球的体外药物释放速率,用HPLC法检测药物浓度。结果显示,制备得到的甲磺酸沙喹那韦三甲基壳聚糖微球在体外近中性及酸性条件下能够持续释放,无突释现象。甲磺酸沙喹那韦三甲基壳聚糖微球有利于口服给药后,药物的持续释放。 In order to improve the bioavailability of saquinavir mesylate,saquinavir mesylate loaded N-trimethyl chitosan microspheres was prepared and their vitro dissolution was studied. Saquinavir mesylate loaded N- trimethyl chitosan microspheres was prepared by spray drying. The formation of microspheres were confirmed by infrared spectroscopy( IR). The drug release rate of microspheres was studied in P BS7. 4 buffer or 0. 1 mol/L hydrochloric acid solution in vitro,and drug concentrations were detected by HP LC. Results showed that saquinavir mesylate loaded N- trimethyl chitosan microspheres was prepared,which released saquinavir mesylate in neutral and acidic conditions continuously in vitro,without any sudden release. Microspheres were suitable for gastrointestinal drug delivery.
出处 《广州化工》 CAS 2016年第6期55-57,共3页 GuangZhou Chemical Industry
基金 浙江省大学生科技创新项目(2013R433005) 宁波市科技局社会发展项目(2010C50035)
关键词 甲磺酸沙喹那韦 三甲基壳聚糖 微球 saquinavir mesylate N-trimethyl chitosan microspheres
  • 相关文献

参考文献3

二级参考文献15

  • 1张瑞涛,王晖,陈丽.均匀设计法筛选盐酸川芎嗪促透剂组方的最佳配比[J].中草药,2007,38(1):50-52. 被引量:11
  • 2USP.[S] .25th ed.2002:1553-1554.
  • 3HUY R H,FERENC F,YVONNE B,et al.Determination of saquinavir in human plasma by high-performance liquid chroatography[J].J Chromatogr B,1997,694:427-433.
  • 4HUGEN P W H,VERWEIJVAN W,BURGER D M,et al.Simultaneous determination of the HIV-protease inhibitors indinavir,nelfinavir saquinavir and ritonavir in human plasma by reversed-phase high-performince liquid chromatography[J].J Chromatogr B,1999,727:139-149.
  • 5FRAPPIER S,BREILH D,DIARTE E,et al .Simultaneous determination of ritonavir and saquinavir,two human immunodeficiency virus protease inhibitors,in human serum by high-performance liquid chromatography[J].J Chromatogr B,1998,714:384-389.
  • 6Huang Y C,Yeh M K,Chiang C H.Formulation factors in preparing BTM-chitosan microspheres by spray dryingmethod[J].Inter J Pharm,2002,242(1-2):239-242.
  • 7Desai K G,Park H J.Effect of manufacturing parameters on the characteristics of vitamin C encapsulated tripolyphosphate-chitosan microspheres prepared by spray-drying[J].J Microencapsul,2006,23(1):91-103.
  • 8Corrigan D O,Healy A M,Corrigan O I.Preparation and release of salbutamol from chitosan and chitosan co-spray dried compacts and multiparticulates[J].Eur J Pharm Biopharm,2006,62(3):295-305
  • 9NOBLE S , FAULD D. Saquinavir: a review of its pharmacology and clinical potential in the management of HIV infection [ J ]. Drug, 1996,52( 1 ) :93 -96.
  • 10United States Pharmacopoeia 25 [ S]. 2002: 1553.

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部